Tao Synergies Inc. Common Stock

TAOX XNAS • FINANCE SERVICES

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

30M

Short interest (May 15)

7.6%

Net Short (Jun 03 ): -0.2%

Borrow Fee

8.70%

↓ 0.0%

Available Shares

400K

↑ 107.3%

Price Chart

Company Overview

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

Company Info

Exchange: NASDAQ

Industry: FINANCE SERVICES

CIK: 0001571934

Asset Type: CS

Market Data

Market Cap: $30,037,162

Employees: 4

Status: Active

Short Interest

Current Borrow Fee 8.70%

Range: 8.70% - 9.02%

Available Shares 400K

Range: 250K - 400K

Recent Changes

Fee Change: ↓ 2.8%

Available Change: ↑ 6.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime